Sana Biotechnology Inc vs Simon Property Group Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Simon Property Group Inc trades at $227 (market cap $74.00B). The key difference: Simon Property Group Inc is far larger — about 84.7× Sana Biotechnology Inc's market cap, and Simon Property Group Inc pays a 3.86% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SPG | |
|---|---|---|
Market Cap | $873.84M | $74.00B |
Sector | Health | Real Estate |
52-Week High | $5.92 | $228.70 |
52-Week Low | $2.68 | $160.68 |
Enterprise Value | $848.03M | $102.48B |
Dividend Yield | — | 3.86% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →